Selective estrogen receptor modulators for the chemoprevention of prostate cancer
- 1 April 2001
- Vol. 57 (4) , 68-72
- https://doi.org/10.1016/s0090-4295(00)00944-4
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Chemoprevention of prostate cancer: concepts and strategies.European Urology, 1999
- Comparative distribution of estrogen receptor-α (ER-α) and β (ER-β) mRNA in the rat pituitary, gonad, and reproductive tractSteroids, 1998
- Tissue Distribution and Quantitative Analysis of Estrogen Receptor- (ER ) and Estrogen Receptor- (ER ) Messenger Ribonucleic Acid in the Wild-Type and ER -Knockout MouseEndocrinology, 1997
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors andEndocrinology, 1997
- Is radical prostatectomy primarily a surgical debulking procedure?Urologic Oncology: Seminars and Original Investigations, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Introductory remarks: Development of chemopreventive agents for prostate cancerJournal of Cellular Biochemistry, 1992